Renal & Urology News

Oral Ferric Citrate Shows Efficacy in Phase 3 Trial for Iron Deficiency Anemia of CKD

In a phase 3 trial, oral ferric citrate effectively raised hemoglobin and improved iron parameters in Taiwanese patients with iron deficiency anemia over 16 weeks. Ferric citrate significantly ...
TCTMD

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Ferric carboxymaltose has become the first form of intravenous iron replacement to earn a US Food and Drug Administration indication for heart failure, the manufacturer announced today. Injectafer ...
Business Wire

American Regent Expands Promotional Campaign for Iron Deficiency Anemia Drug Injectafer ® (Ferric Carboxymaltose Injection)

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
Healio

Phase 3 study demonstrates ferric citrate effectively treats iron deficiency anemia

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Keryx Biopharmaceuticals recently reported positive ...
FierceBiotech

Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology

NEW YORK -- Keryx Biopharmaceuticals, Inc. (KERX) (the "Company") announced the publication of results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric citrate), the ...
Healio

Ferric citrate meets goals in phase 3 study for iron deficiency anemia

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Keryx Biopharmaceuticals Inc. said ferric citrate met ...